PMC7731902_01
Timeline of systematic treatment.
fendo-11-594264-g001.jpg
PMC7731902_01_fendo-11-594264-g001.jpg
f1
A timeline of his systemic treatment is provided in  Figure 1 .
Imaging at baseline and after 18 months of nivolumab plus cabozantinib.
fendo-11-594264-g002.jpg
PMC7731902_01_fendo-11-594264-g002.jpg
f2
Cabozantinib was dosed at 40 mg by mouth daily and nivolumab was provided at 240 mg IV every 2 weeks as per the phase I study by Apolo et al.  Figure 2  contrasts his baseline imaging studies with the ones obtained 18 months after treatment initiation.
Right lower extremity shin ulcerations.
fendo-11-594264-g003.jpg
PMC7731902_01_fendo-11-594264-g003.jpg
f3
The patient's course was complicated by several events including ulcerations on his lower extremities shown in  Figure 3 .